Resmed (RSMDF) Current Assets (2010 - 2026)
Resmed's (RSMDF) quarterly Current Assets came in at $4.3 billion in Q2 2026, up 23.37% on a YoY basis from $3.5 billion in Q2 2025, and up 6.41% quarter-over-quarter from $4.1 billion in Q1 2026.
Analysis
Resmed (RSMDF) Current Assets (2010 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Current Assets for 17 consecutive years, with $4.3 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets rose 23.37% year-over-year to $4.3 billion; the trailing twelve-month figure through Jun 2026 stood at $4.3 billion (up 23.37% YoY), and the FY2026 full-year result was $4.3 billion, up 23.37% from the prior year.
- Current Assets advanced to $4.3 billion in Q2 2026 per RSMDF's latest filing, from $4.1 billion in the prior quarter.
- Across five years, Current Assets topped out at $4.3 billion in Q2 2026 and bottomed at $1.7 billion in Q1 2022.
- Historically, Current Assets has averaged $2.8 billion across 5 years, with a median of $2.4 billion in 2023.
- The sharpest annual moves came in 2022 and 2024: Current Assets soared 50.28% in 2022, then decreased 0.43% in 2024.
- Over 5 years, Current Assets stood at $2.3 billion in 2022, then climbed by 2.28% to $2.4 billion in 2023, then increased by 19.26% to $2.8 billion in 2024, then jumped by 34.65% to $3.8 billion in 2025, then climbed by 13.25% to $4.3 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $4.3 billion, $4.1 billion, and $3.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 4.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Bn |
| Mar 31, 2026 | 4.06 Bn |
| Dec 31, 2025 | 3.82 Bn |
| Sep 30, 2025 | 3.63 Bn |
| Jun 30, 2025 | 3.51 Bn |
| Mar 31, 2025 | 3.21 Bn |
| Dec 31, 2024 | 2.84 Bn |
| Sep 30, 2024 | 2.64 Bn |
| Jun 30, 2024 | 2.36 Bn |
| Mar 31, 2024 | 2.35 Bn |
| Dec 31, 2023 | 2.38 Bn |
| Sep 30, 2023 | 2.30 Bn |
| Jun 30, 2023 | 2.37 Bn |
| Mar 31, 2023 | 2.34 Bn |
| Dec 31, 2022 | 2.33 Bn |
| Sep 30, 2022 | 2.03 Bn |
| Jun 30, 2022 | 1.93 Bn |
| Mar 31, 2022 | 1.70 Bn |
| Dec 31, 2021 | 1.55 Bn |
| Sep 30, 2021 | 1.59 Bn |